Taiwo Adesoye

9PUBLICATIONS
27CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 22, 2026
Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial.

|Apr 08, 2026
Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early-Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.

Jennifer H Chen, Kerollos Nashat Wanis, Mahdia Rahman

|Nov 24, 2025
Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach.

Taiwo Adesoye, Ecaterina E Dumbrava, Kanwal P S Raghav

|May 28, 2025
Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancers.

|Feb 10, 2024
Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics.

Taiwo Adesoye, Debasish Tripathy, Kelly K Hunt

|Aug 08, 2023
Patient-reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment.

Taiwo Adesoye, Kai-Ping Liao, Susan Peterson

Pageof 2

Frequent Collaborators

3 joint publications

Funda Meric-Bernstam

2 joint publications

Debasish Tripathy

2 joint publications

Paula R Pohlmann

1 joint publications

Mariana Chavez-MacGregor